Dorlol^®

Therapeutic Segment:
Anti-glucoma

Generic Name:
Dorzolamide/Timolol

Indication:
DORLOL® is indicated in the treatment of elevated intraocular
pressure (IOP).

Contraindication:
DORLOL® is contraindicated in patients with:

• bronchial asthma or the history of bronchial asthma, or severe chronic obstructive pulmonary disease.
• sinus bradycardia, second or third degree artrioventricular block, overt cardiac failure, cardiogenic shock.
• hypersensitivity to any component of this product The above are based on the components and are not unique to the combination.

Formulation:

• Eye Drop

Strength:

• 20mg+5mg/ml

Pack Size:

• 5ml